openPR Logo
Press release

RNAi Technology Market to be Worth $4,506.5 Million by 2030, Expanding at a CAGR of 11.1% from 2023 to 2030 | QIAGEN, Dicerna Pharmaceuticals, Phio Pharmaceuticals Corp

01-05-2023 03:40 PM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

RNAi Technology Market

RNAi Technology Market

According to a research report "RNAi Technology Market, By Application (Drug Discovery and Development and Therapeutics) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" RNA-based treatments have received a lot of attention in recent years because of their potential to cure a wide range of chronic diseases such as cancer, diabetes, AIDS, tuberculosis, and certain cardiovascular ailments, as well as uncommon and hereditary abnormalities. Despite being in the clinical research phase, RNA-based medicines have been investigated as a possible treatment option for difficult-to-treat disorders. This therapeutic's development is based on promising technologies such as RNA interference (RNAi), antisense technology, and SMaRT technology. RNAi and antisense technologies are gaining popularity in the research business as they give the base sequence for developing RNA therapeutics.

The RNAi Technology market size is expected to reach US$ 4,506.5 million by 2030, as per the new report by Coherent Market Insights, Inc., expanding at a CAGR of 11.1% from 2023 to 2030.

Request a Sample of this Report at

What's New for 2023?

▹Global competitiveness and key competitor market share percentages
▹Strong/Active/Niche/Trivial market presence across multiple geographies
▹Online interactive peer-to-peer collaborative bespoke updates

Key Players in This Report Include:

❖ Dicerna Pharmaceuticals Inc.
❖ Phio Pharmaceuticals Corp.
❖ Arcturus Therapeutics
❖ Ionis Pharmaceuticals Inc.
❖ Sigma Aldrich (Merck KGaA)
❖ Benitec Biopharma Ltd.
❖ Silence Therapeutics PLC
❖ SBI Biotech Co. Ltd.
❖ Alnylam Pharmaceuticals Inc.
❖ Thermo Fisher Scientific Inc.

Coverage: All major geographies and key segments

Regions Covered in the RNAi Technology Market:

❖ North America (United States, Canada and Mexico)
❖ Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)
❖ Asia Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).
❖ South America (Brazil, Argentina, Venezuela, Ecuador, Peru, Colombia and Chile etc.)
❖ Middle East & Africa (South Africa, UAE, Saudi Arabia and Israel, Egypt etc.)

Get Purchase this Premium Report, click here (Up To 25% Discount) @:

Report Overview:

This report includes a thorough examination of the market's key growth factors, constraints, challenges, and opportunities. A thorough examination of the RNAi Technology. This report provides market size, recent trends, growth, share, development status, dynamics, cost structure, and the competitive landscape. The study of RNAi Technology industry players of market and top investment pockets currently operating in the industry is covered in the report.

The research highlights key industry developments, challenges, and competition, as well as gap analysis and new opportunities and trends in the RNAi Technology Market. The report includes a thorough examination of the market's macroeconomic and microeconomic factors. Furthermore, an in-depth examination of the market's critical elements, such as restraints, drivers, supervisory scenarios, past and present trends, and technological advancement.

Competitive Outlook:

The report includes global RNAi Technology Market key players as well as some small players for competitor analysis. The report provides a comprehensive analysis supported by accurate competitor sales and revenue statistics. The report describes the vendor market competition situation, company profile, price analysis, and value chain. Furthermore, their market share, sales growth, gross margin, production, revenue, product portfolio, and other important factors are considered.

Request for customization in Report @

Aim of the study:

• Market size by primary regions/nations, as well as other segments included in the study, are considered and analyzed.
• Better understanding of the market structure.
• Focuses on Market Players to define, portray, and investigate the value, share, market rivalry scene, SWOT analysis, and future development plans.
• To look into the market's distinctive development patterns, future prospects, and overall commitment.
• To communicate detailed information about the key factors influencing market growth (growth potential, industry-explicit difficulties, and dangers).
• To evaluate the market size in comparison to key regions (along with their respective key countries).
• To examine market developments such as market expansions, collaborations, new product launches, and acquisitions for competition analysis.
• To provide a strategic profile of the important players, as well as a comprehensive analysis of their growth strategies.

Objectives of the Report:

✅ To carefully analyze and forecast the size of the RNAi Technology market by value and volume.

✅ To estimate the market shares of major segments of the RNAi Technology

✅ To showcase the development of the RNAi Technology market in different parts of the world.

✅ To analyze and study micro-markets in terms of their contributions to the RNAi Technology market, their prospects, and individual growth trends.

✅ To offer precise and useful details about factors affecting the growth of the RNAi Technology

✅ To provide a meticulous assessment of crucial business strategies used by leading companies operating in the RNAi Technology market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Have a look on Sample Version of Report at


Research Methodology Used

Analysts used primary and secondary research methodologies to create a comprehensive analysis for this report. It then validates industry experts' market estimates, findings, and assumptions. Finally, the report estimates all segments and sub-segments using data triangulation and breakup procedures.

Furthermore, the study investigates the global presence of the global RNAi Technology Market through an economy-wide evaluation as well as a detailed study on product costs, demands, profit analysis, drivers and constraints, production, distribution, and year-on-year growth rate. The preferences of consumers and future insights highlighted in this report will provide companies with a complete picture of the market during the forecast period.

Contact Us

Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us

Coherent Market Insights is a global market intelligence and consulting firm that offers syndicated market research reports, bespoke market research reports, and consulting services. We are known for providing actionable insights and authentic reports in a wide range of domains, including aerospace and defense, agricultural, food and beverages, automotive, chemicals and materials, and almost every other domain and sub-domain under the sun. We provide value to our clients' businesses by providing extremely trustworthy and accurate reports. We are also committed to taking the lead in providing insights in many sectors post-COVID-19 and to continuing to deliver quantifiable, long-term results for our clients.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNAi Technology Market to be Worth $4,506.5 Million by 2030, Expanding at a CAGR of 11.1% from 2023 to 2030 | QIAGEN, Dicerna Pharmaceuticals, Phio Pharmaceuticals Corp here

News-ID: 2872998 • Views: 380

More Releases from Coherent Market Insights (CMI)

Sarcopenia Treatment Market Booming Worldwide | SWOT Analysis | Future Scope | F …
According to the report published by Coherent Market Insights, This report studies the Sarcopenia Treatment Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provide a thorough analysis of the global market, taking into account the important leading stakeholders of the Sarcopenia Treatment industry. Sarcopenia is a condition characterized by a loss of muscle mass and strength that commonly
Rising Trends of Orlistat Market to Huge Growth and Future Scope 2023-2030 | Roc …
According to the report published by Coherent Market Insights, This report studies the Orlistat Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provide a thorough analysis of the global market, taking into account the important leading stakeholders of the Orlistat industry. The study clearly demonstrates the market's history and current conditions as well as anticipated market size and
Rapid Medical Diagnostic Kits Market Booming Growth | Challenges Potential Benef …
"Coherent Market Insights offers a 45% discount on Rapid Medical Diagnostic Kits Market Reports on Single User Access and Unlimited User Access" The rapid medical diagnostic kits market is a rapidly growing segment of the healthcare industry, driven by the increasing demand for quick and accurate diagnoses. Rapid medical diagnostic kits are designed to provide fast and reliable results in a variety of settings, including hospitals, clinics, and even in the
Healthcare IT Outsourcing Market to be Garner $97729.3 Million by 2030, Expandin …
According to a research report "Healthcare IT Outsourcing Market, By Application (Payer Outsourcing (Hospital Information System, Laboratory Information System, Radiology Information System, Electronic Medical Records, and Other Types), and Providers Outsourcing (Revenue Cycle Management System and Healthcare Analytics)) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" In the healthcare information technology business, outsourcing is a new phenomenon. It is a screening procedure in which an organisation chooses the

All 5 Releases

More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event ( opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and